SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

Vascular Biogenics Ltd. (VBLT)

VBLT RSS Feed
Add VBLT Price Alert      Hide Sticky   Hide Intro
Moderator: gr8db8
Search This Board: 
Last Post: 3/27/2017 9:23:03 AM - Followers: 29 - Board type: Free - Posts Today: 2

Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its clinical pipeline is based on two platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. As of June 6, 2014, it has developed two programs based on these platforms an oncology program and an anti-inflammatory program. Its lead product candidate from its oncology program, VB-111, is a gene-based biologic that is initially developing for recurrent glioblastoma (rGBM), an aggressive form of brain cancer. The Company has also received orphan drug designation in both the United States and Europe. The Company’s oncology program is based on its Vascular Targeting System (VTS), platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. http://www.vblrx.com
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VBLT
Current Price
Volume:
Bid Ask Day's Range
SureTrader
VBLT News: Annual and Transition Report (foreign Private Issuer) (20-f) 07:06 AM
VBLT News: VBL Therapeutics to Present at the Oppenheimer 27th Annual Healthcare Conference 03/15/2017 07:00:00 AM
VBLT News: VBL Therapeutics to Present at the 29th Annual ROTH Conference 03/07/2017 07:00:00 AM
VBLT News: VBL Therapeutics to Report Full-Year 2016 Financial Results on March 27 03/02/2017 08:00:00 AM
VBLT News: Report of Foreign Issuer (6-k) 02/21/2017 07:28:06 AM
News News Alert: Annual and Transition Report (foreign Private Issuer) (20-f) 03/27/2017 07:06:13 AM
PostSubject
#638  Sticky Note The extended survival tail is encouraging, and indicates gr8db8 02/24/17 01:11:22 PM
#743   2 clues in his words first greenlight alone Oren1976 03/27/17 09:23:03 AM
#742   My impression from webcast earning the control in Oren1976 03/27/17 09:10:30 AM
#741   oren, small margin calls work the way you gr8db8 03/24/17 11:17:34 AM
#740   Most chance it's what u said and not Oren1976 03/23/17 11:13:57 PM
#739   IMHO, this was a manipulation attempt to shake Bubbonian Wall 03/23/17 09:14:08 PM
#738   The sell yesterday can still be due to Oren1976 03/23/17 05:22:21 PM
#737   On the bright side, we did not lose wcopeland 03/23/17 04:57:16 PM
#736   Stock market is in such a panic. kpisme 03/23/17 04:05:44 PM
#735   WTF... yesterday down over a buck, today, jumps davidal66 03/23/17 04:03:37 PM
#734   Since the stock has rebounded today, it looks gr8db8 03/23/17 12:20:57 PM
#733   Yeah maybe they dumped some shares yesterday. MF82 03/23/17 11:41:53 AM
#732   5 looks right. kpisme 03/23/17 10:24:59 AM
#731   LOL when I guess he bought back today. kpisme 03/23/17 10:22:46 AM
#730   News out this morning VBLT hosting a key mjw007 03/23/17 07:32:03 AM
#729   Not a bad thing to be Thai Lee. davidal66 03/22/17 09:49:44 PM
#728   My take. Whoever sold wanted to cause this gr8db8 03/22/17 09:21:11 PM
#727   A final possibility... could there have been some davidal66 03/22/17 08:13:34 PM
#726   Several possibilities: davidal66 03/22/17 08:08:37 PM
#725   Up slightly after hrs... see what tomorrow brings MF82 03/22/17 06:41:39 PM
#724   New drug supposed to be exposed in few Oren1976 03/22/17 05:28:43 PM
#723   But wouldn't that be a material fact to davidal66 03/22/17 05:17:12 PM
#722   Maybe dropouts they kept speaking in earning conference Oren1976 03/22/17 05:13:53 PM
#721   Insider sell which is bad sign. Usually cause Oren1976 03/22/17 05:07:35 PM
#720   Stamp says the 17th. Was public. kpisme 03/22/17 05:04:38 PM
#719   Go to stocktwits forum . Oppenheimer sold today Oren1976 03/22/17 04:55:40 PM
#718   I thought they said they had enough money kpisme 03/22/17 04:40:12 PM
#717   Couldn't be trial failure...would have seen a dump MF82 03/22/17 04:34:22 PM
#716   My guess dilution I hope not toxicity death Oren1976 03/22/17 04:32:27 PM
#715   Wtf happened? MF82 03/22/17 04:22:59 PM
#714   250 K shares or so sold off in davidal66 03/22/17 04:01:47 PM
#713   The closing seems to have a run for davidal66 03/22/17 03:58:04 PM
#712   Or maybe something was said that was less davidal66 03/22/17 03:55:30 PM
#711   Massive dumping action near close... wonder if a davidal66 03/22/17 03:51:02 PM
#710   109 events can happen on any arm. Assuming gr8db8 03/22/17 11:59:39 AM
#709   http://www.cherylbroyles-gbm.com she lives around 20 years with Oren1976 03/22/17 02:39:00 AM
#708   That is a great point Oren. Many companies wcopeland 03/22/17 02:00:41 AM
#707   Can they decide to stop the trial before Oren1976 03/22/17 02:00:39 AM
#706   252 patients in trial. What if 109 Oren1976 03/22/17 01:58:51 AM
#705   Why am I so sure ? Couple of Oren1976 03/22/17 01:50:23 AM
#704   This what will happen. We will.have to be Oren1976 03/22/17 01:36:25 AM
#703   Based on your assumptions, I would think that gr8db8 03/22/17 01:23:03 AM
#702   Let's assume VB111 passes Ph3 rGBM and OVCA. wcopeland 03/22/17 01:05:06 AM
#701   Agree. It wouldn't surprise me if solid interim gr8db8 03/21/17 12:17:18 PM
#700   Me too, but with one caveat. If it davidal66 03/20/17 10:37:03 PM
#699   I hope they don't/never get acquired. I want gr8db8 03/20/17 10:30:01 PM
#698   I missed this interesting tidbit from the recent davidal66 03/20/17 01:55:46 AM
#697   Dr. Said his tumor had shrunk by 37%.... MF82 03/19/17 08:17:57 PM
#696   Pretty cool to see vb111 in a news MF82 03/19/17 08:14:10 PM
#695   It is also to maintain/build relationship with the gr8db8 03/15/17 04:08:34 PM
#694   I think the data in phase II thyroid davidal66 03/15/17 02:44:59 PM
PostSubject